MAM
GMAB icon

Madison Asset Management’s Genmab GMAB Stock Holding History

Madison Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.9M Buy
70,970
+4,479
+7% +$134K 0.02% 259
2025
Q4 		$2.05M Buy
66,491
+4,999
+8% +$156K 0.02% 245
2025
Q3 		$1.89M Sell
61,492
-1,438
-2% -$35K 0.02% 244
2025
Q2 		$1.3M Buy
62,930
+567
+0.9% +$11.6K 0.01% 273
2025
Q1 		$1.22M Buy
62,363
+15,459
+33% +$324K 0.01% 269
2024
Q4 		$979K Sell
46,904
-20,785
-31% -$457K 0.01% 285
2024
Q3 		$1.65M Buy
67,689
+9,114
+16% +$244K 0.02% 267
2024
Q2 		$1.47M Sell
58,575
-3,099
-5% -$87.9K 0.02% 272
2024
Q1 		$1.84M Buy
61,674
+12,732
+26% +$374K 0.02% 265
2023
Q4 		$1.56M Sell
48,942
-26,493
-35% -$832K 0.02% 272
2023
Q3 		$2.66M Buy
75,435
+8,738
+13% +$333K 0.04% 232
2023
Q2 		$2.54M Sell
66,697
-607
-0.9% -$24.2K 0.04% 238
2023
Q1 		$2.54M Buy
67,304
+8,495
+14% +$327K 0.04% 232
2022
Q4 		$2.49M Sell
58,809
-12,630
-18% -$520K 0.04% 227
2022
Q3 		$2.29M Buy
71,439
+14,777
+26% +$519K 0.04% 233
2022
Q2 		$1.84M Sell
56,662
-4,386
-7% -$142K 0.03% 270
2022
Q1 		$2.21M Buy
61,048
+11,066
+22% +$380K 0.03% 236
2021
Q4 		$1.98M Sell
49,982
-16,014
-24% -$668K 0.03% 252
2021
Q3 		$2.88M Buy
65,996
+10,953
+20% +$492K 0.04% 241
2021
Q2 		$2.25M Sell
55,043
-9,939
-15% -$384K 0.03% 254
2021
Q1 		$2.13M Sell
64,982
-4,821
-7% -$181K 0.03% 251
2020
Q4 		$2.84M Buy
+69,803
New +$2.61M 0.04% 237

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Madison Asset Management's GMAB Position: Q1 2026 in Review

Madison Asset Management increased its Genmab (GMAB) stake by 6.7% in Q1 2026, buying an estimated $134K and bringing the position to 70,970 shares worth $1.9M. The position accounts for 0.02% of the portfolio, ranked #259.

Madison Asset Management first reported a position in GMAB in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.88M in Q3 2021. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Madison Asset Management held 70,970 shares of Genmab worth $1.9M as of Q1 2026.
  • Madison Asset Management bought 4,479 Genmab shares in Q1 2026, an estimated $134K.
  • Genmab made up 0.02% of Madison Asset Management's portfolio in Q1 2026, its #259 holding.
  • Madison Asset Management first reported a position in Genmab in Q4 2020 and has held it in 22 quarters since.
  • Madison Asset Management's Genmab position peaked at $2.88M in Q3 2021.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Madison Asset Management's 13F filing for Q1 2026, filed 7 May 2026.